Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1205, Genève, Switzerland.
Radiation Oncology Department, Geneva University Hospital, CH-1211, 14, Geneva, Switzerland.
Radiat Oncol. 2018 Jun 19;13(1):114. doi: 10.1186/s13014-018-1059-1.
This is a dosimetric comparative study intended to establish appropriate low-to-intermediate dose-constraints for the rectal wall (R) in the context of a randomized phase-II trial on urethra-sparing stereotactic body radiotherapy (SBRT) for prostate cancer. The effect of plan optimization on low-to-intermediate R dose and the potential benefit of an endorectal balloon (ERB) are investigated.
Ten prostate cancer patients, simulated with and without an ERB, were planned to receive 36.25Gy (7.25Gyx5) to the planning treatment volume (PTV) and 32.5Gy to the urethral planning risk volume (uPRV). Reference plans with and without the ERB, optimized with respect to PTV and uPRV coverage objectives and the organs at risk dose constraints, were further optimized using a standardized stepwise approach to push down dose constraints to the R in the low to intermediate range in five sequential steps to obtain paired plans with and without ERB (Vm to Vm). Homogeneity index for the PTV and the uPRV, and the Dice similarity coefficient (DSC) for the PTV were analyzed. Dosimetric parameters for R including the median dose and the dose received by 10 to 60% of the R, bladder wall (B) and femoral heads (F) were compared. The monitor units (MU) per plan were recorded.
Vm reduced by half D, D, D and D for R and decreased by a third D while HI, HI and DSC remained stable with and without ERB compared to Vm. HI worsened at Vm both with and without ERB. No statistical differences were observed between paired plans on R, B except a higher D for F with and without an ERB.
Further optimization to the R in the context of urethra sparing prostate SBRT is feasible without compromising the dose homogeneity to the target. Independent of the use or not of an ERB, low-to-intermediate doses to the R can be significantly reduced using a four-step sequential optimization approach.
这是一项旨在为保留尿道的前列腺立体定向体部放疗(SBRT)建立合适的直肠壁(R)低-中剂量约束的剂量学比较研究。该研究调查了计划优化对低-中 R 剂量的影响,以及内置式直肠气囊(ERB)的潜在益处。
对 10 例前列腺癌患者进行模拟,包括有和没有 ERB 的情况,计划对计划靶区(PTV)给予 36.25Gy(7.25Gyx5),对尿道计划危险靶区(uPRV)给予 32.5Gy。在 PTV 和 uPRV 覆盖目标以及危及器官剂量约束的基础上,对有和没有 ERB 的参考计划进行优化,然后使用标准化逐步方法进一步优化,将 R 剂量降低到低-中剂量范围的五个连续步骤中,以获得有和没有 ERB 的配对计划(Vm 至 Vm)。分析 PTV 和 uPRV 的均匀性指数(HI)以及 PTV 的 Dice 相似系数(DSC)。比较 R 包括中位剂量和 R、膀胱壁(B)和股骨头(F)的 10%至 60%所接受剂量的剂量学参数。记录每个计划的监测单位(MU)。
Vm 时,R 的 D、D、D 和 D 减少一半,而 HI、HI 和 DSC 保持稳定,有和没有 ERB 相比,Vm 时减少三分之一。有和没有 ERB 时,Vm 时 HI 均恶化。配对计划在 R 和 B 之间没有观察到统计学差异,除了有和没有 ERB 时 F 的 D 较高。
在保留尿道的前列腺 SBRT 中,对 R 进行进一步优化是可行的,不会影响靶区的剂量均匀性。无论是否使用 ERB,使用四步序贯优化方法都可以显著降低 R 的低-中剂量。